Navigation Links
For Breast Cancer Treatment, an Agent That Can Achieve an Overall Survival Benefit Would Pose the Greatest Challenge to Avastin's Dominance in Europe
Date:12/15/2009

nd Spain--Italy has the greatest percentage of eligible patients who do not receive Avastin treatment for breast cancer due to cost," said Decision Resources Analyst Niamh Murphy, Ph.D. "Additionally, in the United Kingdom, Avastin is not reimbursed through the National Health Service."

European Trends in Targeted Therapies in Breast Cancer: A Clinician and Payer Perspective on the Current and Future Uptake is based on surveys with 224 oncologists and interviews with 20 hospital-based payers in Germany, France, Italy, Spain and the United Kingdom. Their responses were compared to assess similarities and differences of opinion regarding clinical, economic and scientific factors.

About Decision Resources

Decision Resources (www.decisionresources.com) is a world leader in market research publications, advisory services, and consulting designed to help clients shape strategy, allocate resources, and master their chosen markets. Decision Resources is a Decision Resources, Inc. company.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.


    For more information, contact:

    Decision Resources              Decision Resources, Inc.
    Christopher Comfort             Elizabeth Marshall
    781-296-2597                    781-296-2563
    
SOURCE Decision Resources
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Xeloda XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
3. Xeloda(R) XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
4. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
5. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
6. Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer
7. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
8. New Study Demonstrates 4 Year Olds Fed Enfamil LIPIL(R) as Infants Have Brain and Eye Outcomes Similar to Breastfed Babies
9. Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease
10. Spit for the Cure Offers Unique Opportunity for Women to Participate in Breast Cancer Research
11. Genomic Health Announces Preliminary Results From a Study of Oncotype DX(TM) in Node-Positive Breast Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... 2015 Research and Markets ( ... the "Wound Care -Traditonal, Advanced And ... And Forecasts" report to their offering. ... of the global Wound Care products market, ... offerings, competitive shares, financial performance, technology developments ...
(Date:7/27/2015)... 2015 According to the new ... (2014-2019) by Type (DNA ISH, RNA ISH), By Application ... (Hospitals, Pharma & Biotech Companies, Research Labs, CROs)", The ... 2014 and is estimated to reach $681.0 million by ... period, 2014 to 2019. Browse through the ...
(Date:7/27/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/v4wlnk/key_pharma_news ) has ... News Issue" newsletter to their offering. ... oncology pipeline and serves as a statement of ... 2015, with a large-scale potentially transformative acquisition by ... Pharma News covers all major developments in the ...
Breaking Medicine Technology:Global Wound Care Markets 2015-2020 - Traditonal, Advanced And Regenerative: Competitors And Opportunities 2Global In-Situ Hybridization Market to be Worth $681.0 Million by 2019 2Global In-Situ Hybridization Market to be Worth $681.0 Million by 2019 3Key Pharma News Issue - Gilead will make further oncology deals in 2015 2Key Pharma News Issue - Gilead will make further oncology deals in 2015 3
... Colo., Oct. 14, 2011 Data presented at ... in Chicago, IL show that the pretreatment blood-based ... carcinoma (RCC) patients treated with a combination of ... by survival outcomes.   Patients who tested VeriStrat ...
... Pharmaceuticals, Inc. announced Friday a significant expansion of its ... methyl, and to continue advancing its earlier-stage pipeline. ... Paul Audhya, MD, as Vice President of ... Ph.D., as Vice President and Chief Regulatory and Compliance ...
Cached Medicine Technology:VeriStrat® Results Correlate with Survival Outcomes in Kidney Cancer Patients 2VeriStrat® Results Correlate with Survival Outcomes in Kidney Cancer Patients 3Reata Pharmaceuticals Adds Executives to Management Team and Board of Directors 2Reata Pharmaceuticals Adds Executives to Management Team and Board of Directors 3
(Date:7/28/2015)... ... July 28, 2015 , ... North American Seminars will ... fall of 2015 . These seventeen courses are pre-approved for CME credit ... Functional Mobility in the Older Adult , August 22, 2015 - August ...
(Date:7/28/2015)... ... ... the Veterans Fund of the United States, managing the United Veteran Beacon House (UVBH) for ... to help homeless Veterans by giving them “A hand up – not a hand out.” ... assists and supports Vets through the Veterans Fund of the United States (VFUS), ...
(Date:7/27/2015)... ... July 28, 2015 , ... Combination Product GMP Compliance:, Understanding FDA’s New ... http:// http://www.fdanews.com/comboproductgmpcompliance , Manufacturing a drug or device is hard ... can get messy in a hurry. In a 46-page draft guidance released in January, ...
(Date:7/27/2015)... , ... July 28, 2015 , ... The National ... inductee into the NAPW VIP Woman of the Year Circle. She is recognized with ... 200 operating Local Chapters, NAPW is the nation’s leading networking organization exclusively for professional ...
(Date:7/27/2015)... ... July 27, 2015 , ... ... wound center management. Earlier this year Wound Care Advantage beta launched ... for WCA wound centers. Customized learning paths allow for clinicians, physicians, hyperbaric ...
Breaking Medicine News(10 mins):Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 2Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 3Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 4Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 5Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 6Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 7Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 8Health News:Veterans Fund of the United States Launches “Adopt A Homeless Veteran” Campaign 2Health News:Veterans Fund of the United States Launches “Adopt A Homeless Veteran” Campaign 3Health News:FDAnews Announces — Combination Product GMP Compliance: Understanding FDA’s New Streamline Approach Webinar, Aug. 19, 2015 2Health News:FDAnews Announces — Combination Product GMP Compliance: Understanding FDA’s New Streamline Approach Webinar, Aug. 19, 2015 3Health News:FDAnews Announces — Combination Product GMP Compliance: Understanding FDA’s New Streamline Approach Webinar, Aug. 19, 2015 4Health News:NAPW Inducts Deana Skidmore, Assistant Director of Nursing at Wilton Meadows Rehablilitation and Health Care Center, Into its VIP Woman of the Year Circle 2Health News:Wound Care Advantage Launches Luvo University An Online Hub For Wound Care Education and Training 2Health News:Wound Care Advantage Launches Luvo University An Online Hub For Wound Care Education and Training 3
... distributed to Kids attending the event with their parents. Food, Entertainment ... ,Florida KidCare - Back to School - Enrollment Fair Sunday, August 3, ... - Shoppes of Cresthaven - (Military Trail & Cresthaven Blvd) West Palm ... ...
... 1 Mark Merritt, President,of the Pharmaceutical ... response to new comparative effectiveness legislation,introduced late ... Max Baucus,(D-Mont.) and Senate Budget Committee Chair ... Baucus and Conrad for helping advance the,discussion ...
... 1 Community-based oral health,programs in Michigan, Ohio, ... to $5,000 from the Delta Dental Foundation,s third ... by Nancy E. Hostetler,senior vice president of the ... of $70,000 will be awarded in competitive grants,this ...
... it,s unclear whether treating the breathing disorder cuts the ... News) -- The interrupted nighttime breathing of sleep apnea ... report. , Earlier studies have linked sleep apnea to ... in sleep centers rather than in the general community. ...
... 2008) -- Quality of care varies greatly for the treatment ... country and category of health care facility, suggesting the potential ... to a new study that was published in the Aug. ... (2008: Vol. 26, Issue 22). , The inconsistencies in care ...
... of Medicine have discovered that a protein called FOXA2 controls ... liver. FOXA2 may become the focus for new therapies to ... study was published online this week in Nature Medicine ... in the gall bladder and transported through ducts to the ...
Cached Medicine News:Health News:Florida KidCare News Conference and Back to School Enrollment Fair 2Health News:Delta Dental Foundation Calls for Applicants for Annual Community Mini-Grant Program 2Health News:Sleep Apnea Boosts Death Risk 2Health News:Sleep Apnea Boosts Death Risk 3Health News:Disparities in prostate cancer treatment suggest ways to improve care 2Health News:Penn researchers find a new role for a 'Foxy Old Gene' 2
... provide you with everything you need ... evoked potential, or electro-oculogram. The ultra-bright ... to perform ERGs you never imagined ... negative response, and s-cone ERGs. Wireless ...
The PersonalLAB junior is an automated microplate analyzer capable of fully automating immunoenzymatic techniques using a microplate format, per the reagent manufacturer's instruction for use and spe...
... designed for high throughput microplate processing. The ... Stacker that handles up to 60 microplates ... model is equipped with a dual direct ... may be interfaced to increase flexibility as ...
... Processor is a precise, reliable and ... has been designed for OEM production. ... customised according to the method bottles ... able to process automatically the whole ...
Medicine Products: